Recombinant Chromobacterium violaceum Siroheme synthase (cysG)

Shipped with Ice Packs
In Stock

Description

Functional Overview of Siroheme Synthase (cysG)

Siroheme synthase (cysG) is a multifunctional enzyme responsible for converting uroporphyrinogen III (Uro-III) into siroheme, a critical cofactor for sulfite/nitrite reductases and other metabolic enzymes . Its catalytic activities include:

  • S-adenosylmethionine (SAM)-dependent bismethylation of Uro-III to precorrin-2 and precorrin-1 .

  • NAD+-dependent dehydrogenation of precorrin-2 to sirohydrochlorin .

  • Iron chelation to form siroheme .

Catalytic StepEnzyme ActivitySubstrate → ProductCofactors/Requirements
MethylationSAM-dependent methyltransferaseUro-III → Precorrin-2SAM
DehydrogenationNAD+-dependent oxidasePrecorrin-2 → SirohydrochlorinNAD+
ChelationFerrochelataseSirohydrochlorin + Fe → SirohemeFe²⁺

Catalytic Specificity

  • CysG exhibits iron specificity in chelation, distinguishing it from cobalt-requiring enzymes in cobalamin biosynthesis .

  • Structural studies (e.g., Salmonella enterica cysG) reveal distinct substrate-binding poses for precorrin-2, sirohydrochlorin, and cobalt-sirohydrochlorin, enabling sequential catalysis .

Metabolic Crossroads

CysG diverts flux from:

  1. Protoporphyrin IX biosynthesis (heme branch) via Uro-III methylation .

  2. Cobalamin biosynthesis (precorrin-2 → sirohydrochlorin) .

Phylogenetic Distribution

CysG is conserved in enteric bacteria (e.g., E. coli, Salmonella) but absent in Klebsiella aerogenes, which employs alternative pathways .

Hypothetical Considerations for Chromobacterium violaceum

While no direct data exists for Chromobacterium violaceum, cysG’s role in:

  • Sulfur metabolism: Siroheme-dependent sulfite/nitrite reduction .

  • Cobalamin biosynthesis: Potential regulatory points at precorrin-2 .

Potential Research Directions:

  1. Gene cloning and expression: Recombinant cysG production in heterologous systems (e.g., E. coli) for functional assays .

  2. Enzyme kinetics: Determination of K<sub>m</sub> and V<sub>max</sub> for Uro-III, SAM, and NAD+ .

  3. Structural validation: X-ray crystallography to confirm domain architecture and substrate-binding modes .

Table 1: CysG Activities in Model Organisms

OrganismMethylationDehydrogenationChelationKey Reference
E. coli✔️ (SAM-dependent)✔️ (NAD+ dependent)✔️ (Fe²⁺)
Salmonella✔️✔️✔️
Klebsiella

Table 2: Reaction Pathway for Siroheme Biosynthesis

StepReactionEnzyme DomainSubstrate → Product
1MethylationMethyltransferaseUro-III → Precorrin-2
2MethylationMethyltransferasePrecorrin-2 → Precorrin-1
3DehydrogenationDehydrogenasePrecorrin-1 → Sirohydrochlorin
4ChelationFerrochelataseSirohydrochlorin + Fe → Siroheme

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
cysG; cobA2; CV_0813Siroheme synthase [Includes: Uroporphyrinogen-III C-methyltransferase; Urogen III methylase; EC 2.1.1.107; SUMT; Uroporphyrinogen III methylase; UROM); Precorrin-2 dehydrogenase; EC 1.3.1.76); Sirohydrochlorin ferrochelatase; EC 4.99.1.4)]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-470
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chromobacterium violaceum (strain ATCC 12472 / DSM 30191 / JCM 1249 / NBRC 12614 / NCIMB 9131 / NCTC 9757)
Target Names
cysG
Target Protein Sequence
MEFFPIFLKL RHQRCLLVGG GEVALRKARL LLAAGASLQV VAPELAPELA DLAERGELEH LPGRYAPALL DGMRLAVAAT DDAEVNRAVA ADAEARGILV NVVDDAEASR YISPAIIDRS PLMVAVASGG SVPVLARSIR ARLESLIPAG YGRLARFGSS FRDAVKARFP DVDARRRFWE TVLEGPLADA VMNGDEAAAR AEMEKRIAAG GADRAGAVYL VGAGPGNPDL LTFRALRLMQ QADVVLYDKL VAPELLELVR RDAERVYVGK ARANHALPQD DINQLLVDLA RQGKRVLRLK GGDPFTFGRG GEEIATLAEH GIAFEVVPGI TSASGAAAYA GIPLTHRDYA QSVTFVTGHK QDGSIDLDWQ ALTRPQQTVV VYMGVSTAAE LCQAFVDNGR AASTPAAAVE WATTERQRTV CGTLAALPGL MASHGIASPA LIIVGEVVEL ADKLSWYRRS ENSAVTIQED
Uniprot No.

Target Background

Function

Recombinant Chromobacterium violaceum Siroheme Synthase (cysG): Background and Function

This multifunctional enzyme catalyzes several key steps in siroheme biosynthesis. First, it performs SAM-dependent methylations of uroporphyrinogen III at positions C-2 and C-7, forming precorrin-2 via precorrin-1. Next, it catalyzes the NAD-dependent ring dehydrogenation of precorrin-2 to yield sirohydrochlorin. Finally, it facilitates the ferrochelation of sirohydrochlorin to produce siroheme.

Database Links

KEGG: cvi:CV_0813

STRING: 243365.CV_0813

Protein Families
Precorrin-2 dehydrogenase / sirohydrochlorin ferrochelatase family; Precorrin methyltransferase family

Q&A

What is Siroheme synthase (cysG) and what reactions does it catalyze?

Siroheme synthase (cysG) from Chromobacterium violaceum is a multifunctional enzyme of 470 amino acids (50.2 kDa) that catalyzes three sequential reactions in the siroheme biosynthetic pathway. The enzyme first performs SAM-dependent methylations of uroporphyrinogen III at positions C-2 and C-7 to form precorrin-2 via the intermediate precorrin-1. Subsequently, it catalyzes the NAD-dependent ring dehydrogenation of precorrin-2 to yield sirohydrochlorin. Finally, it facilitates the ferrochelation of sirohydrochlorin to produce siroheme .

The trifunctional nature of this enzyme makes it particularly interesting for biochemical studies, as it exhibits three distinct catalytic activities within a single polypeptide chain. This distinguishes it from homologous proteins in some other organisms where these activities are distributed across separate enzymes.

What is the role of siroheme as a cofactor in biological systems?

Siroheme serves as a critical cofactor in a conserved class of sulfite and nitrite reductases that catalyze the six-electron reduction of sulfite to sulfide and nitrite to ammonia . These reactions are fundamental to the sulfur and nitrogen assimilation pathways in many organisms. The unique structure of siroheme, with its isobacteriochlorin ring system and iron center, provides the necessary electronic environment for these challenging multi-electron reduction reactions.

In C. violaceum specifically, these reductive pathways contribute to the organism's metabolic versatility, allowing it to adapt to various environmental conditions including nutrient-limited settings. The siroheme-dependent enzymes are integral to C. violaceum's ability to utilize inorganic nitrogen and sulfur sources for biosynthetic purposes.

What expression systems are most effective for producing recombinant C. violaceum cysG?

When designing expression systems for recombinant C. violaceum cysG, researchers should consider several factors to optimize protein yield and activity. E. coli-based expression systems are commonly employed due to their ease of use and high yield potential. The BL21(DE3) strain is particularly suitable as it lacks certain proteases that could degrade the recombinant protein.

For optimal expression, the following methodological considerations should be implemented:

  • Codon optimization: The C. violaceum cysG sequence should be codon-optimized for expression in E. coli to improve translation efficiency.

  • Temperature control: Expression at lower temperatures (16-25°C) often improves protein folding.

  • Induction conditions: IPTG concentration (typically 0.1-0.5 mM) and induction timing (preferably at mid-log phase) should be optimized.

  • Fusion tags: A polyhistidine tag facilitates purification via nickel affinity chromatography, while MBP or SUMO tags can improve solubility.

The full-length sequence of 470 amino acids from C. violaceum strain ATCC 12472 should be used as the template for cloning . Researchers should verify successful expression through SDS-PAGE analysis, with the expected molecular weight of approximately 50.2 kDa, potentially higher if fusion tags are included.

How can quasi-experimental designs be applied to study cysG function in vivo?

When studying cysG function in vivo, quasi-experimental designs offer valuable approaches when true experimental conditions cannot be established. These designs are particularly useful for investigating cysG in its native context within C. violaceum or in heterologous hosts.

More robust quasi-experimental approaches include:

  • Interrupted time-series design: Measuring siroheme production before and after induction of cysG expression at multiple time points.

  • Nonequivalent control group design: Comparing strains with different levels of cysG expression or with mutations in specific domains.

  • Regression discontinuity design: Evaluating the effect of cysG expression across a continuous variable like growth phase or nutrient availability.

When implementing these designs, researchers should account for potential confounding variables such as growth conditions, competing metabolic pathways, and the regulatory influence of quorum sensing systems, which are known to affect gene expression in C. violaceum .

How does the bifunctional active site of cysG accommodate both dehydrogenation and chelation reactions?

The bifunctional active site of siroheme synthase (cysG) demonstrates remarkable versatility in catalyzing two chemically distinct reactions: NAD⁺-dependent dehydrogenation and iron chelation. Recent structural studies have provided insights into this dual functionality.

The enzyme appears to orient substrates differently for each reaction through conformational changes in the active site. When bound to precorrin-2, the enzyme positions the substrate for optimal interaction with NAD⁺, facilitating the dehydrogenation reaction to produce sirohydrochlorin . Subsequently, the active site undergoes conformational changes to accommodate iron insertion into sirohydrochlorin.

Research indicates that specific residues within the active site play crucial roles in substrate orientation. The binding of sirohydrochlorin (the dehydrogenation product/chelation substrate) induces structural rearrangements that create a suitable environment for iron coordination . These mechanisms allow the enzyme to efficiently catalyze sequential reactions within a single active site without releasing intermediates.

Methodologically, researchers investigating this bifunctionality should consider:

  • Site-directed mutagenesis of key residues to evaluate their roles in each reaction

  • Spectroscopic techniques to monitor substrate binding and product formation

  • Computational modeling to identify potential conformational changes during catalysis

How is cysG expression regulated in C. violaceum and how does this differ from other bacteria?

The regulation of cysG expression in C. violaceum involves complex cellular signaling networks. Although direct evidence for cysG regulation is limited in the search results, parallels can be drawn with other biosynthetic pathways in C. violaceum.

Quorum sensing (QS) plays a significant role in regulating various metabolic pathways in C. violaceum. The CviI/CviR QS system, which utilizes N-acyl-homoserine lactones (AHLs) as signaling molecules, regulates virulence factors and biosynthetic pathways, including violacein production . By analogy, cysG expression might be similarly regulated, particularly as siroheme production relates to the organism's ability to utilize different nutrient sources.

In contrast to C. violaceum, in other bacteria like Janthinobacterium, the regulation of violacein biosynthesis involves JqsR response regulator binding sites upstream of the vioABCDE gene cluster . The presence of biosynthetic gene clusters (BGCs) for quorum sensing signaling homoserine lactone molecules correlates with strong violacein production in certain Janthinobacterium strains .

For methodological investigation of cysG regulation in C. violaceum, researchers should consider:

  • Reporter gene assays using the cysG promoter region

  • Quantitative RT-PCR analysis under different growth conditions

  • Chromatin immunoprecipitation to identify transcription factors binding to the cysG promoter

  • Comparative analysis with regulation patterns in related bacteria

What role does quorum sensing play in modulating siroheme biosynthesis in C. violaceum?

While direct evidence linking quorum sensing to siroheme biosynthesis in C. violaceum is not explicitly presented in the search results, several lines of evidence suggest potential connections that warrant investigation.

C. violaceum employs the CviI/CviR quorum sensing system that utilizes AHLs for cell-to-cell communication . This system regulates multiple virulence factors and biosynthetic pathways, including violacein production. Given that metabolic pathways in bacteria are often co-regulated to optimize resource allocation, it is plausible that siroheme biosynthesis, which is essential for sulfur and nitrogen metabolism, might be coordinated with other cellular processes through quorum sensing.

The evidence from Janthinobacterium provides an interesting parallel, where strains with strong violacein production possess biosynthetic gene clusters for AHL production . This suggests that quorum sensing might similarly influence other specialized metabolic pathways like siroheme biosynthesis.

Researchers investigating this relationship should consider:

  • Comparative analysis of cysG expression in wild-type and quorum sensing mutant strains (ΔcviI or ΔcviR)

  • Assessment of siroheme production at different cell densities

  • Testing the effects of exogenous AHLs on cysG expression and siroheme production

  • Promoter analysis to identify potential CviR binding sites upstream of the cysG gene

How does C. violaceum cysG differ from siroheme synthases in other organisms?

Comparative analysis reveals interesting differences between C. violaceum cysG and siroheme synthases from other organisms:

OrganismEnzyme StructureCatalytic ActivitiesSize (kDa)Notable Features
C. violaceumTrifunctionalMethylation, Dehydrogenation, Chelation50.2Single polypeptide with three distinct activities
Salmonella entericaTrifunctionalMethylation, Dehydrogenation, Chelation~50Bifunctional active site for dehydrogenation and chelation
E. coliTrifunctionalMethylation, Dehydrogenation, Chelation~50Similar to S. enterica CysG
Some cyanobacteriaSplit enzymesActivities distributed across multiple proteinsVariesPathway distributed across separate enzymes

The C. violaceum cysG belongs to the precorrin methyltransferase family, particularly in its C-terminal section . This evolutionary conservation suggests the importance of this enzyme in basic metabolic functions across diverse bacterial species.

The unique aspects of C. violaceum cysG may relate to adaptations to its ecological niche. C. violaceum is known for its virulence factors and specialized metabolites like violacein , and the specific characteristics of its cysG enzyme might reflect adaptations to its environmental conditions and metabolic requirements.

What evolutionary insights can be gained from analyzing cysG sequences across different Chromobacterium species?

Evolutionary analysis of cysG sequences across Chromobacterium species can provide valuable insights into functional conservation and adaptation. Though the search results don't provide direct comparative data for cysG across Chromobacterium species, we can infer methodological approaches based on similar analyses performed for other genes.

The phylogenetic analysis approach used for Janthinobacterium strains based on 49 highly conserved Clusters of Orthologous Groups (COG) domains could be adapted for analyzing cysG evolution in Chromobacterium. Such analysis would help determine whether cysG evolution follows species evolution or shows evidence of horizontal gene transfer or functional adaptation.

Key methodological considerations for evolutionary analysis include:

  • Multiple sequence alignment of cysG sequences from diverse Chromobacterium isolates

  • Construction of phylogenetic trees using both full-length sequences and individual functional domains

  • Calculation of selection pressures (dN/dS ratios) across different regions of the gene

  • Comparative analysis of gene synteny around the cysG locus

These analyses could reveal whether certain domains are under stronger evolutionary constraints, potentially indicating their critical functional importance. Additionally, comparison with siroheme synthases from other bacterial genera could provide insights into the broader evolutionary history of this enzyme family.

What are the common challenges in assaying the multiple enzymatic activities of cysG and how can they be overcome?

Assaying the multiple enzymatic activities of cysG presents several technical challenges due to the sequential nature of the reactions and the chemical properties of the intermediates and products. Researchers frequently encounter the following issues:

  • Substrate availability: Uroporphyrinogen III, the initial substrate, is unstable and sensitive to oxidation. Researchers can overcome this by:

    • Generating uroporphyrinogen III enzymatically in situ using recombinant hemC and hemD enzymes

    • Performing reactions under strictly anaerobic conditions

    • Using chemical reducing agents like sodium borohydride to maintain reducing conditions

  • Monitoring multiple reactions: Tracking the three sequential activities requires different detection methods. A comprehensive approach involves:

    • UV-visible spectroscopy to monitor the characteristic absorption spectra of precorrin-2 (λmax ≈ 400 nm), sirohydrochlorin (λmax ≈ 376 nm), and siroheme (λmax ≈ 385 nm)

    • HPLC analysis with fluorescence detection for separating and quantifying reaction intermediates

    • Mass spectrometry for definitive identification of products and intermediates

  • NAD+ regeneration: The dehydrogenation reaction requires NAD+, which is converted to NADH. To maintain consistent activity:

    • Include an NAD+ regeneration system (e.g., lactate dehydrogenase and pyruvate)

    • Monitor NADH formation spectrophotometrically at 340 nm as an indirect measure of dehydrogenase activity

  • Iron incorporation: The chelation reaction requires ferrous iron, which is prone to oxidation. Researchers should:

    • Use freshly prepared ferrous ammonium sulfate under anaerobic conditions

    • Include reducing agents like ascorbate or dithiothreitol

    • Control pH carefully as iron solubility is pH-dependent

How can researchers troubleshoot expression and purification issues with recombinant C. violaceum cysG?

Researchers working with recombinant C. violaceum cysG may encounter several expression and purification challenges. Here are systematic approaches to troubleshoot common issues:

  • Poor expression levels:

    • Optimize codon usage for the expression host

    • Test multiple expression strains (BL21(DE3), Rosetta, Arctic Express)

    • Adjust induction conditions (temperature, IPTG concentration, induction time)

    • Consider using stronger promoters or higher copy number vectors

  • Protein insolubility:

    • Lower expression temperature (16-20°C)

    • Use solubility-enhancing fusion partners (MBP, SUMO, thioredoxin)

    • Include compatible solutes (glycerol, sorbitol) in the growth medium

    • Try autoinduction media instead of IPTG induction

  • Loss of activity during purification:

    • Include cofactors (SAM, NAD+) in purification buffers

    • Add reducing agents to prevent oxidation of cysteine residues

    • Use gentle elution conditions and avoid extreme pH

    • Include protease inhibitors to prevent degradation

  • Heterogeneous product:

    • Implement additional purification steps (ion exchange, size exclusion)

    • Analyze potential post-translational modifications by mass spectrometry

    • Check for proteolytic cleavage by SDS-PAGE and western blotting

    • Optimize storage conditions to prevent aggregation or degradation

The full-length sequence of C. violaceum cysG contains numerous charged residues that may affect solubility . Analysis of the amino acid composition and secondary structure prediction can guide the design of optimized constructs with enhanced expression and stability.

How can recombinant C. violaceum cysG be utilized in biosynthetic pathway engineering?

Recombinant C. violaceum cysG offers significant potential for biosynthetic pathway engineering due to its multifunctional nature. Researchers can leverage this enzyme in several applications:

  • Production of specialized tetrapyrroles: By incorporating cysG into engineered pathways, researchers can produce siroheme and related tetrapyrroles for use as cofactors or precursors in the biosynthesis of other porphyrin-based molecules. The trifunctional nature of cysG allows for efficient conversion of uroporphyrinogen III to siroheme without releasing potentially toxic intermediates.

  • Pathway optimization: The domain structure of cysG can be exploited to create chimeric enzymes with altered substrate specificity or improved catalytic efficiency. By combining domains from different siroheme synthases, researchers may develop enzymes with novel functions or enhanced properties.

  • Metabolic engineering applications: Integration of cysG into microorganisms can enhance their ability to utilize inorganic sulfur and nitrogen sources through improved siroheme-dependent reductase activities. This could be particularly valuable for engineering strains for bioremediation of sulfite or nitrite-contaminated environments.

  • Cofactor engineering: Modifications to the cysG gene could potentially yield variants of siroheme with altered electronic properties, potentially creating novel biocatalysts with unique reactivities.

What insights from C. violaceum cysG structure-function relationships could inform drug development targeting bacterial metabolic pathways?

Understanding the structure-function relationships of C. violaceum cysG provides valuable insights that could inform antimicrobial drug development:

  • Targeting essential metabolic pathways: Siroheme is critical for sulfur and nitrogen assimilation in many bacteria. Since these pathways are absent in mammals, inhibitors of siroheme biosynthesis could potentially serve as selective antimicrobials with minimal host toxicity.

  • Multi-target inhibition strategy: The multifunctional nature of cysG presents opportunities for designing inhibitors that simultaneously disrupt multiple catalytic functions. Compounds binding at domain interfaces might be particularly effective by disrupting the coordination between the enzyme's various activities.

  • Species-specific inhibitors: Comparative analysis of cysG from different bacterial species could reveal structural differences that might be exploited to develop narrow-spectrum antimicrobials targeting specific pathogens, reducing disruption to beneficial microbiota.

  • Allosteric regulation: Understanding how the different domains of cysG communicate during catalysis could inform the development of allosteric inhibitors that disrupt enzyme function without directly competing with substrates.

Methodologically, structure-based drug design approaches could include:

  • Virtual screening against the bifunctional active site that catalyzes both dehydrogenation and chelation

  • Fragment-based drug discovery focusing on domain interfaces

  • Analysis of transition states for each catalytic step to design transition state analogs as potent inhibitors

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.